Invention Grant
US07897623B2 ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
有权
ω-羧基芳基取代的二苯脲作为p38激酶抑制剂
- Patent Title: ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
- Patent Title (中): ω-羧基芳基取代的二苯脲作为p38激酶抑制剂
-
Application No.: US11845597Application Date: 2007-08-27
-
Publication No.: US07897623B2Publication Date: 2011-03-01
- Inventor: Bernd Riedl , Jacques Dumas , Uday R. Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
- Applicant: Bernd Riedl , Jacques Dumas , Uday R. Khire , Timothy B. Lowinger , William J. Scott , Roger A. Smith , Jill E. Wood , Mary-Katherine Monahan , Reina Natero , Joel Renick , Robert N. Sibley
- Applicant Address: US NY Tarrytown
- Assignee: Bayer Healthcare LLC
- Current Assignee: Bayer Healthcare LLC
- Current Assignee Address: US NY Tarrytown
- Agency: Millen, White, Zelano & Branigan, P.C.
- Main IPC: A61K31/44
- IPC: A61K31/44
Abstract:
This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.
Public/Granted literature
- US20080027061A1 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors Public/Granted day:2008-01-31
Information query
